Valuation: Cello Health plc

Market Cap 179M 237M 209M 197M 336M 22.76B 338M 2.36B 912M 11.61B 890M 871M 37.32B P/E 2024
43.4x
P/E 2025 -109x
Enterprise Value 179M 237M 209M 197M 336M 22.76B 338M 2.36B 912M 11.62B 890M 871M 37.33B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
-
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 51 12/08/2020
Director/Board Member 47 14/12/2023

Financials

2024 2025
Net sales - -
Net income 4.12M 5.47M 4.81M 4.55M 7.75M 525M 7.79M 54.45M 21.03M 268M 20.53M 20.09M 861M -1.64M -2.17M -1.91M -1.8M -3.07M -208M -3.09M -21.6M -8.34M -106M -8.14M -7.97M -341M
Net Debt 1.34M 1.78M 1.56M 1.48M 2.52M 171M 2.53M 17.7M 6.84M 87.08M 6.67M 6.53M 280M 42K 55.68K 48.97K 46.31K 78.88K 5.34M 79.34K 554K 214K 2.73M 209K 205K 8.76M
Logo Cello Health plc
Cello Health plc, formerly Cello Group plc, is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company provides a range of biotech, diagnostics, devices and other non-healthcare clients. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company's pharmaceutical and healthcare clients. The Cello Signal Division provides market research and direct communications services to the Company's consumer facing clients. The Company delivers its services from office networks in the United Kingdom, the United States and Singapore.
Employees
-
Sector
-